etoposide has been researched along with tn14003 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burger, JA; Burger, M; Fujii, N; Glodek, A; Hartmann, TN | 1 |
Braun, F; Burger, M; Catusse, J; Kayser, G; Reichardt, W; Taromi, S; von Elverfeldt, D; Weber, WA; Zeiser, R | 1 |
2 other study(ies) available for etoposide and tn14003
Article | Year |
---|---|
CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
Topics: Apoptosis; Carcinoma, Small Cell; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Chemokines, CXC; Collagen; Drug Resistance, Neoplasm; Etoposide; Fibronectins; Humans; Integrins; Lung Neoplasms; Peptides; Phosphotyrosine; Receptors, CXCR4; rho GTP-Binding Proteins; Signal Transduction | 2005 |
CXCR4 antagonists suppress small cell lung cancer progression.
Topics: Animals; Benzylamines; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cisplatin; Cyclams; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Mice, Knockout; Neoplasm Metastasis; Nuclear Proteins; Peptides; Receptors, CXCR4; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays | 2016 |